Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Sep. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Chris Twitty [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On August 25, 2025, Chris Twitty, the Company’s Chief Scientific Officer, adopted a Rule 10b5-1 trading plan. Dr. Twitty's Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c ) under the Exchange Act ("Rule 10b5-1(c)") and provides for the potential sale of up to 154,832 shares of the Company’s common stock subject to restricted stock units and stock options held by Dr. Twitty until December 31, 2026.
|
| Title | Chief Scientific Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | August 25, 2025 |
| Expiration Date | December 31, 2026. |
| Arrangement Duration | 493 days |
| Aggregate Available | 154,832 |